Product Code: 978-1-68038-001-9
Incontinence And Ostomy Care Products Market Growth & Trends:
The global incontinence and ostomy care products market size is anticipated to reach USD 25.7 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 5.3% from 2023 to 2030. The increasing incidence of colorectal cancer and urological diseases, such as Inflammatory Bowel Disease (IBD), urinary incontinence, and benign prostatic hyperplasia is anticipated to boost the market growth.
The growing risk of colorectal and urinary bladder cancer has increased the demand for ostomy care products. For instance, the American Cancer Society has reported that in 2019, the number of colorectal cases in the U.S. has increased to 101,420. This is expected to drive the growth of the market at a global level.
Increasing awareness initiatives by several market players to raise cognizance regarding these prosthetic medical devices globally is successfully breaking the stigma and taboo associated with the use of these products. For instance, Coloplast is a leading market player and has recently published Ostomy Life Study Review to raise awareness and improve the standard of ostomy care. This helps in effective patient care, building their confidence, and inspires them to live a quality life.
Moreover, the outbreak of COVID-19 has spurred the demand for incontinence products used in home settings. Since the majority of consumers are aged/seniors, there is a higher demand for these products. Restrictions on movement at international borders have created an opportunity for local players to enter the market and meet the unmet demands of the end-users. In November 2020, NorthShore Care Supply announced a free trial of 2 bags of adult diapers and a discount on all absorbents for ICU Nurses or other COVID first responders.
Incontinence And Ostomy Care Products Market Report Highlights:
- Based on type, the incontinence care products segment held the largest revenue share of around 75.3% in 2022. This can be attributed to the increasing cases of urological diseases, such as IBD, colon cancer, and bladder control problems
- The incontinence care products segment is further segmented into absorbents, incontinence bags, and others. Whereas, the ostomy care products segment is sub-divided into ostomy bags, deodorants, skin barriers, and irrigation products
- Europe dominated the market in 2022 with the largest revenue share of around 42.8%, owing to the increasing prevalence of urological diseases, supportive government policies, and increasing awareness programs
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Type
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Incontinence and Ostomy Care Products Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
- 3.4. Incontinence and Ostomy Care Products Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
Chapter 4. Incontinence and Ostomy Care Products: Type Estimates & Trend Analysis
- 4.1. Incontinence and Ostomy Care Products Market, Key Takeaways
- 4.2. Incontinence and Ostomy Care Products Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. Incontinence Care Products
- 4.3.1. Incontinence care products market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.2. Absorbents
- 4.3.2.1. Absorbents market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.3. Incontinence bags
- 4.3.3.1. Incontinence bags market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.4. Others
- 4.3.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Ostomy Care Products
- 4.4.1. Ostomy care products market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.2. Ostomy bags
- 4.4.2.1. Ostomy bags market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.3. Deodorants
- 4.4.3.1. Deodorants market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.4. Skin barriers
- 4.4.4.1. Skin barriers market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.5. Irrigation products
- 4.4.5.1. Irrigation products market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Incontinence and Ostomy Care Products Market: Regional Estimates & Trend Analysis
- 5.1. Regional Outlook
- 5.2. Incontinence and Ostomy Care Products Market by Region: Key Takeaways
- 5.3. North America
- 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.3.2. U.S.
- 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.3.3. Canada
- 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4. Europe
- 5.4.1. UK
- 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4.2. Germany
- 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4.3. France
- 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4.4. Italy
- 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4.5. Spain
- 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4.6. Denmark
- 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4.7. Sweden
- 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4.8. Norway
- 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.5. Asia Pacific
- 5.5.1. Japan
- 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.5.2. China
- 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.5.3. India
- 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.5.4. Australia
- 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.5.5. Thailand
- 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.5.6. South Korea
- 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.6. Latin America
- 5.6.1. Brazil
- 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.6.2. Mexico
- 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.6.3. Argentina
- 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.7. MEA
- 5.7.1. South Africa
- 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.7.2. Saudi Arabia
- 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.7.3. UAE
- 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.7.4. Kuwait
- 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
- 6.1. Recent Developments & Impact Analysis, By Key Market Participants
- 6.2. Company/Competition Categorization
- 6.2.1. Coloplast A/S
- 6.2.1.1. Company overview
- 6.2.1.2. Financial performance
- 6.2.1.3. Product Benchmarking
- 6.2.1.4. Strategic initiatives
- 6.2.2. Essity Aktiebolag (publ).
- 6.2.2.1. Company overview
- 6.2.2.2. Financial performance
- 6.2.2.3. Product benchmarking
- 6.2.2.4. Strategic initiatives
- 6.2.3. KCWW (Kimberly-Clark Corporation)
- 6.2.3.1. Company overview
- 6.2.3.2. Financial performance
- 6.2.3.3. Product benchmarking
- 6.2.3.4. Strategic initiatives
- 6.2.4. B. Braun SE
- 6.2.4.1. Company overview
- 6.2.4.2. Financial performance
- 6.2.4.3. Product benchmarking
- 6.2.4.4. Strategic initiatives
- 6.2.5. Hollister Incorporated
- 6.2.5.1. Company overview
- 6.2.5.2. Financial performance
- 6.2.5.3. Product benchmarking
- 6.2.5.4. Strategic initiatives
- 6.2.6. Unicharm Corporation
- 6.2.6.1. Company overview
- 6.2.6.2. Financial performance
- 6.2.6.3. Product benchmarking
- 6.2.6.4. Strategic initiatives
- 6.2.7. ConvaTec Group Plc
- 6.2.7.1. Company overview
- 6.2.7.2. Financial performance
- 6.2.7.3. Product benchmarking
- 6.2.7.4. Strategic initiatives
- 6.2.8. Welland Medical Limited.
- 6.2.8.1. Company overview
- 6.2.8.2. Financial performance
- 6.2.8.3. Product benchmarking
- 6.2.8.4. Strategic initiatives
- 6.2.9. Domtar Corporation
- 6.2.9.1. Company overview
- 6.2.9.2. Financial performance
- 6.2.9.3. Product benchmarking
- 6.2.9.4. Strategic initiatives
- 6.2.10. Salts Healthcare Ltd.
- 6.2.10.1. Company overview
- 6.2.10.2. Financial performance
- 6.2.10.3. Product benchmarking
- 6.2.10.4. Strategic initiatives